Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

15
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic landscape of Mexican patients with maturity onset diabetes of the young: beyond mutations in MODY-known genes.

Frontiers in endocrinology·2026
Same author

Role of Tumor Volume and Prolactin Ratios in Differentiating Prolactinomas and Predicting Response to Cabergoline.

Archives of medical research·2026
Same author

Unconventional Uses of Human Growth Hormone.

Archives of medical research·2026
Same author

Single-cell epigenetic landscape, microenvironment interactions, and gene regulatory modules of non-functioning pituitary adenomas.

Cell systems·2026
Same author

Increased mortality in patients with non-functioning pituitary tumors: a study in a tertiary center.

Frontiers in endocrinology·2025
Same author

Consensus on acromegaly therapeutic outcomes: an update.

Nature reviews. Endocrinology·2025

Related Experiment Video

Updated: Apr 26, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.5K

Pituitary apoplexy in nonfunctioning pituitary macroadenomas: a case-control study.

Guadalupe Vargas1, Baldomero Gonzalez2, Gerardo Guinto3

  • 1Endocrinology Service/Experimental Endocrinology Unit.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|August 8, 2014
PubMed
Summary

Pituitary apoplexy (PA) is a medical emergency in patients with nonfunctioning pituitary macroadenomas (NFPMAs). Prior use of dopamine agonists and oculomotor abnormalities are key indicators for developing PA.

More Related Videos

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

26.6K
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

11.1K

Related Experiment Videos

Last Updated: Apr 26, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.5K
A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

26.6K
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

11.1K

Area of Science:

  • Endocrinology
  • Neurosurgery
  • Oncology

Background:

  • Pituitary apoplexy (PA) is a critical condition involving pituitary adenomas, presenting with severe symptoms.
  • Nonfunctioning pituitary macroadenomas (NFPMAs) are common tumors, but factors leading to PA are not fully understood.

Purpose of the Study:

  • To determine the incidence, precipitating factors, clinical features, and outcomes of PA in patients with NFPMAs.
  • To identify specific risk factors differentiating PA development in NFPMA patients.

Main Methods:

  • A retrospective case-control study involving 46 PA patients and 47 matched controls with NFPMAs.
  • Analysis included clinical, hormonal, and tumoral characteristics, precipitating factors, and long-term outcomes using bivariate and multivariate analyses.

Main Results:

  • The incidence of PA was 8%. Oculomotor paralysis was significantly more common in PA cases (18%) than controls.
  • Prior use of dopamine agonists was a significant predictor for PA development in both bivariate and multivariate analyses.
  • Visual and endocrine outcomes were similar across conservative, early surgical, and late surgical management groups.

Conclusions:

  • PA is a life-threatening emergency associated with NFPMAs.
  • Dopamine agonist use and oculomotor abnormalities are distinct indicators for PA in NFPMA patients.
  • Management strategies, including conservative and surgical options, yield similar visual and endocrine outcomes.